We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+16.51%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$1.93B
AUM Growth
-$485M
(-20%)
Cap. Flow
-$562M
Cap. Flow
% of AUM
-29.17%
Top 10 Holdings %
Top 10 Hldgs %
5.51%
Holding
3,496
New
1,220
Increased
551
Reduced
717
Closed
1,006
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$10.4M |
| 2 |
Cisco
CSCO
|
+$7.97M |
| 3 |
American Tower
AMT
|
+$7.79M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$7.33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$16.2M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$15.1M |
| 3 |
Amazon
AMZN
|
+$13.7M |
| 4 |
Philip Morris
PM
|
+$13.5M |
| 5 |
Amphenol
APH
|
+$12.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14% |
| 3 | Healthcare | 12.51% |
| 4 | Consumer Discretionary | 11.31% |
| 5 | Industrials | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Alto Ingredients
ALTO
$345M
| $42.5K | ﹤0.01% |
+39,322
| New | +$44.2K |
|
|
BSIN
2202
Big Sky Industrial
BSIN
$58.1M
| $42.3K | ﹤0.01% |
35,841
-9,000
| -20% | -$11K |
|
2203
Codexis
CDXS
$161M
| $42.2K | ﹤0.01% |
17,304
-30,188
| -64% | -$82.3K |
|
2204
reAlpha
AIRE
$7.56M
| $41.7K | ﹤0.01% |
+2,173
| New | +$27.8K |
|
2205
Century Casinos
CNTY
$32.6M
| $41.6K | ﹤0.01% |
15,950
-8,384
| -34% | -$20.9K |
|
|
CAPT
2206
DELISTED
Captivision
CAPT
| $40.8K | ﹤0.01% |
+43,486
| New | +$55K |
|
|
NTCL
2207
NetClass Technology Inc
NTCL
$4.31M
| $40.2K | ﹤0.01% |
+551
| New | +$47.3K |
|
2208
RenovoRx
RNXT
$40.9M
| $40.2K | ﹤0.01% |
+31,615
| New | +$37.6K |
|
2209
XBiotech
XBIT
$69.2M
| $40K | ﹤0.01% |
15,056
-5,352
| -26% | -$15.8K |
|
|
KNDI
2210
Kandi Technologies Group
KNDI
$63.5M
| $39.6K | ﹤0.01% |
+32,714
| New | +$42.3K |
|
2211
Pyxis Oncology
PYXS
$184M
| $39.3K | ﹤0.01% |
17,699
-18,681
| -51% | -$26.9K |
|
|
GGRP
2212
Glimpse Group
GGRP
$19.4M
| $39.2K | ﹤0.01% |
23,900
-9,785
| -29% | -$14.5K |
|
|
GRML
2213
Greenland Mines Ltd
GRML
$29.9M
| $38.7K | ﹤0.01% |
+79,801
| New | +$69.2K |
|
2214
Nautilus Biotechnolgy
NAUT
$152M
| $38.6K | ﹤0.01% |
45,724
-20,470
| -31% | -$15K |
|
|
ITOC
2215
iTonic Holdings
ITOC
$4.42M
| $38.5K | ﹤0.01% |
+49,408
| New | +$354K |
|
2216
Heron Therapeutics
HRTX
$92M
| $38.4K | ﹤0.01% |
+30,497
| New | +$48.4K |
|
|
ZYXI
2217
DELISTED
Zynex
ZYXI
| $38.3K | ﹤0.01% |
26,411
+8,286
| +46% | +$15.2K |
|
2218
Austin Gold Corp
AUST
$13.1M
| $38.2K | ﹤0.01% |
21,963
-11,964
| -35% | -$17.8K |
|
|
NVNO
2219
enVVeno Medical
NVNO
$6.94M
| $38.1K | ﹤0.01% |
1,201
+697
| +138% | +$71.2K |
|
|
ZEO
2220
Zeo Energy
ZEO
$18.6M
| $38K | ﹤0.01% |
+28,181
| New | +$56.8K |
|
|
WHWK
2221
Whitehawk Therapeutics
WHWK
$182M
| $37.6K | ﹤0.01% |
+19,780
| New | +$36.4K |
|
|
FARM
2222
DELISTED
Farmer Brothers
FARM
| $37.6K | ﹤0.01% |
21,972
-20,325
| -48% | -$35.2K |
|
2223
Senti Biosciences Holdings
SNTI
$11.9M
| $37.5K | ﹤0.01% |
+26,567
| New | +$44.4K |
|
|
RVPH
2224
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $37K | ﹤0.01% |
5,020
+922
| +22% | +$7.84K |
|
2225
Momentus
MNTS
$85.3M
| $36.9K | ﹤0.01% |
+1,566
| New | +$34.9K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q3 2025 Portfolio in Review
As of Q3 2025, XTX Topco held 3,496 positions worth $1.93B, down 20% from $2.41B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco withdrew a net $562M in Q3 2025, closing 1,006 positions and reducing 717 holdings. Its most notable exit was T-Mobile US, an estimated $9.81M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, XTX Topco opened a new position in Johnson & Johnson worth $11.3M.
- XTX Topco's largest Q3 2025 buy was Johnson & Johnson: 60,929 shares worth $11.3M.
- XTX Topco added most to Invesco QQQ Trust in Q3 2025, an estimated $7.33M increase.
- XTX Topco's biggest Q3 2025 reduction was Oracle, cutting an estimated $16.2M.
- XTX Topco fully exited T-Mobile US in Q3 2025, selling an estimated $9.81M.
- XTX Topco's ten largest holdings make up 5.5% of its $1.93B portfolio in Q3 2025.
- XTX Topco opened 1,220 new positions and closed 1,006 in Q3 2025.
- XTX Topco's portfolio value fell 20% quarter-over-quarter to $1.93B.
Based on XTX Topco's 13F filing for Q3 2025, filed 14 Nov 2025.